Details for Patent: RE46856
Which drugs does patent RE46856 protect, and when does it expire?
Patent RE46856 protects ALIQOPA and is included in one NDA.
This patent has fifty-one patent family members in forty-two countries.
Summary for Patent: RE46856
| Title: | Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis |
| Abstract: | This invention relates to novel 2,3-dihydroimidazo[1,2-c]quinazoline compounds, pharmaceutical compositions containing such compounds and the use of those compounds or compositions for phosphotidylinositol-3-kinase (PI3K) inhibition and treating diseases associated with phosphotidylinositol-3-kinase (PI3K) activity, in particular treating hyperproliferative and/or angiogenesis disorders, as a sole agent or in combination with other active ingredients. |
| Inventor(s): | Martin Hentemann, Jill Wood, William Scott, Martin Michels, Ann-Marie Campbell, Ann-Marie Bullion, Bruce R. Rowley, Aniko Redman |
| Assignee: | Bayer AG , Bayer Intellectual Property GmbH |
| Application Number: | US15/398,916 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent RE46856
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bayer Healthcare | ALIQOPA | copanlisib dihydrochloride | POWDER;INTRAVENOUS | 209936-001 | Sep 14, 2017 | DISCN | Yes | No | RE46856 | ⤷ Start Trial | Y | Y | TREATMENT OF ADULT PATIENTS WITH RELAPSED FOLLICULAR LYMPHOMA WHO HAVE RECEIVED AT LEAST TWO PRIOR SYSTEMIC THERAPIES | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: RE46856
| PCT Information | |||
| PCT Filed | December 05, 2007 | PCT Application Number: | PCT/US2007/024985 |
| PCT Publication Date: | June 12, 2008 | PCT Publication Number: | WO2008/070150 |
International Family Members for US Patent RE46856
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 064106 | ⤷ Start Trial | |||
| Australia | 2007328008 | ⤷ Start Trial | |||
| Brazil | PI0720178 | ⤷ Start Trial | |||
| Canada | 2671614 | ⤷ Start Trial | |||
| Chile | 2007003508 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
